Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia.
about
Lipid-lowering efficacy of atorvastatinLipid lowering efficacy of atorvastatinUric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease?Statins in homozygous familial hypercholesterolemiaHMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statinsDo HMG-CoA reductase inhibitors affect fibrinogen?Pleiotropic effects of statins.Beneficial effects of statins in coronary artery disease--beyond lowering cholesterol.Statins and renal function.Familial hypercholesterolemia and response to statin therapy according to LDLR genetic background.Mechanisms for cellular cholesterol transport: defects and human disease.Microsomal transfer protein inhibitors, new approach for treatment of familial hypercholesterolemia, review of the literature, original findings, and clinical significance.Atorvastatin in the treatment of primary hypercholesterolemia and mixed dyslipidemias.New prospects for lipid-lowering drugs.Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia.Statin drugs do not affect serum complement activation in vitro.Bromelain and cardiovascular risk factors in diabetes: An exploratory randomized, placebo controlled, double blind clinical trial.
P2860
Q24187301-6CABBBDC-D853-4D38-A41C-056FCA8D838EQ24202363-EEA40DA3-F51D-4BF9-8C15-B308166FF417Q24678615-925B490C-B739-4390-810A-894AC1BF0124Q28214323-73435593-E70E-4EB2-A92B-B04D033DC840Q28344912-60659F10-778C-4A63-9B79-7F8B54F1474BQ32052986-910D078E-447A-42CA-9658-B1354B1725B0Q34107414-764C47AF-B29D-43AA-B943-2B5A686D23B6Q34122524-4179D99B-66C4-4AF6-83FC-766435AD3259Q34940824-41082176-8A6C-4EA6-8920-037F3EB2EB56Q36275435-D6F8C258-451D-410E-9EB6-4842F6120784Q36610465-1D1709E6-10CD-46FB-81E7-3503F8D45D9EQ38325807-83D57E46-6448-4718-B97D-6865BF295AB8Q38549355-D461D8D1-1766-4E3C-A946-81E14F2A3D3FQ40408992-7C1451CC-5AA3-4094-B0CA-6A4D9167827DQ44571944-4C2691B9-0151-484A-9544-A48E3DDDD42AQ44967045-C2C82265-3669-4B36-925E-D4E4DFB4D091Q50196870-77CC0E27-C006-407B-927F-C5E4A8D724DD
P2860
Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia.
description
1997 nî lūn-bûn
@nan
1997 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia.
@ast
Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia.
@en
Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia.
@nl
type
label
Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia.
@ast
Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia.
@en
Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia.
@nl
prefLabel
Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia.
@ast
Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia.
@en
Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia.
@nl
P2093
P356
P1476
Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia.
@en
P2093
P304
P356
10.1161/01.ATV.17.8.1527
P407
P577
1997-08-01T00:00:00Z